Packaging: new EU directive on medicines

The pharmaceutical industry is undergoing a period of strong growth, a trend confirmed by the WHOdata (World Health Organization) estimates that for the entire sector grew from 300 to 400 billion dollars a year starting in 2017. This increase of economic potential of the sector has facilitated the movement in the market of an increasing number of counterfeit medicines.

The 1% of medicines in circulation in developed countries could be counterfeit, a share that rises to 10% if you take into account worldwide.
The EU Directive on falsified medicines establish new guidelines for pharmaceutical companies related to packaging to solve some of these problems. The new legislation aims to improve safety for patients and reduce the presence of counterfeit medicines in the distribution chain “legal”. From 2018 it will be mandatory for all medicinal products placed on the EU market, comply with the directives.